{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:46:30Z","timestamp":1792273590598,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10735-026-10961-6","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T07:20:07Z","timestamp":1788074407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM26 triggers ferroptosis via ZEB1 degradation to suppress nasopharyngeal carcinoma progression"],"prefix":"10.1007","volume":"57","author":[{"given":"Jing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"10961_CR1","doi-asserted-by":"crossref","unstructured":"Aizaz M et al (2023) Genomic analysis, evolution and characterization of E3 ubiquitin protein ligase (TRIM) gene family in common carp (Cyprinus carpio). Genes (Basel) 14(3)","DOI":"10.3390\/genes14030667"},{"key":"10961_CR2","doi-asserted-by":"publisher","first-page":"102489","DOI":"10.1016\/j.tranon.2025.102489","volume":"60","author":"NS Al-Abbas","year":"2025","unstructured":"Al-Abbas NS (2025) TRIM26 as a dual regulator of ferroptosis and chemoresistance in gastric cancer through HSF1 ubiquitination and exosomal miR-24-3p signaling. Transl Oncol 60:102489","journal-title":"Transl Oncol"},{"issue":"6","key":"10961_CR3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","volume":"30","author":"ET Chang","year":"2021","unstructured":"Chang ET et al (2021) The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev 30(6):1035\u20131047","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Pt 2","key":"10961_CR4","doi-asserted-by":"publisher","first-page":"117554","DOI":"10.1016\/j.bcp.2025.117554","volume":"243","author":"S Chen","year":"2026","unstructured":"Chen S et al (2026) PCDH7 promotes EMT and chemoresistance by stabilizing ZEB1 via inhibition of TRIM26-mediated ubiquitination in lung adenocarcinoma. Biochem Pharmacol 243(Pt 2):117554","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10961_CR5","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s11010-020-04036-7","volume":"476","author":"L Cheng","year":"2021","unstructured":"Cheng L et al (2021) ZEB1: new advances in fibrosis and cancer. Mol Cell Biochem 476(4):1643\u20131650","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10961_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol 25(6):424\u2013442","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10961_CR7","doi-asserted-by":"crossref","unstructured":"Huang H et al (2023) Immunotherapy for nasopharyngeal carcinoma: current status and prospects (Review). Int J Oncol 63(2)","DOI":"10.3892\/ijo.2023.5545"},{"issue":"3","key":"10961_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","volume":"13","author":"H Jiang","year":"2022","unstructured":"Jiang H et al (2022) Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer. Cell Death Dis 13(3):206","journal-title":"Cell Death Dis"},{"issue":"8","key":"10961_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8):599\u2013620","journal-title":"Protein Cell"},{"issue":"8","key":"10961_CR10","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41418-021-00754-7","volume":"28","author":"X Li","year":"2021","unstructured":"Li X et al (2021) Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma. Cell Death Differ 28(8):2315\u20132332","journal-title":"Cell Death Differ"},{"issue":"1","key":"10961_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13020-025-01130-0","volume":"20","author":"L Li","year":"2025","unstructured":"Li L et al (2025) Evodiamine induces ferroptosis in prostate cancer cells by inhibiting TRIM26-mediated stabilization of GPX4. Chin Med 20(1):71","journal-title":"Chin Med"},{"key":"10961_CR12","doi-asserted-by":"publisher","first-page":"113490","DOI":"10.1016\/j.biopha.2022.113490","volume":"153","author":"J Lu","year":"2022","unstructured":"Lu J et al (2022) ZEB1: catalyst of immune escape during tumor metastasis. Biomed Pharmacother 153:113490","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10961_CR13","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1002\/cam4.1537","volume":"7","author":"XM Lyu","year":"2018","unstructured":"Lyu XM et al (2018) A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response. Cancer Med 7(8):3848\u20133861","journal-title":"Cancer Med"},{"key":"10961_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2023.10.001","volume":"97","author":"M Saitoh","year":"2023","unstructured":"Saitoh M (2023) Transcriptional regulation of EMT transcription factors in cancer. Semin Cancer Biol 97:21\u201329","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"10961_CR15","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1002\/ctm2.1204","volume":"13","author":"C Sampson","year":"2023","unstructured":"Sampson C et al (2023) The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. Clin Transl Med 13(3):e1204","journal-title":"Clin Transl Med"},{"issue":"9","key":"10961_CR16","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41556-024-01464-1","volume":"26","author":"A Schwab","year":"2024","unstructured":"Schwab A et al (2024) Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat Cell Biol 26(9):1470\u20131481","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10961_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","volume":"43","author":"ZY Su","year":"2024","unstructured":"Su ZY et al (2024) Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev 43(3):919\u2013939","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"10961_CR18","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.7150\/ijbs.81726","volume":"19","author":"Y Sun","year":"2023","unstructured":"Sun Y et al (2023) TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. Int J Biol Sci 19(9):2803\u20132816","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10961_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S et al (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8(1):372","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10961_CR20","doi-asserted-by":"publisher","first-page":"101358","DOI":"10.1016\/j.bjorl.2023.101358","volume":"90","author":"L Tang","year":"2024","unstructured":"Tang L et al (2024) miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1. Braz J Otorhinolaryngol 90(1):101358","journal-title":"Braz J Otorhinolaryngol"},{"issue":"10","key":"10961_CR21","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.7150\/ijbs.71520","volume":"18","author":"X Wang","year":"2022","unstructured":"Wang X et al (2022) O-GlcNAcylation of ZEB1 facilitated mesenchymal pancreatic cancer cell ferroptosis. Int J Biol Sci 18(10):4135\u20134150","journal-title":"Int J Biol Sci"},{"issue":"10","key":"10961_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41419-023-06222-z","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z et al (2023) The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma. Cell Death Dis 14(10):695","journal-title":"Cell Death Dis"},{"issue":"Pt 4","key":"10961_CR23","doi-asserted-by":"publisher","first-page":"145187","DOI":"10.1016\/j.ijbiomac.2025.145187","volume":"318","author":"D Wang","year":"2025","unstructured":"Wang D et al (2025) circADARB1 enhances ZEB1 expression in an m(6)A-dependent manner to promote the invasion and migration of nasopharyngeal carcinoma. Int J Biol Macromol 318(Pt 4):145187","journal-title":"Int J Biol Macromol"},{"key":"10961_CR24","doi-asserted-by":"crossref","unstructured":"Wang J et al (2023) The ubiquitin-proteasome system in tumor metabolism. Cancers (Basel) 15(8)","DOI":"10.3390\/cancers15082385"},{"issue":"11","key":"10961_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong KCW et al (2021) Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol 18(11):679\u2013695","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10961_CR26","doi-asserted-by":"publisher","first-page":"e23381","DOI":"10.1002\/jbt.23381","volume":"37","author":"C Wu","year":"2023","unstructured":"Wu C et al (2023) Long noncoding RNA ZEB1-AS1 attenuates ferroptosis of gastric cancer cells through modulating miR-429\/BGN axis. J Biochem Mol Toxicol 37(8):e23381","journal-title":"J Biochem Mol Toxicol"},{"issue":"35","key":"10961_CR27","doi-asserted-by":"publisher","first-page":"e202300379","DOI":"10.1002\/anie.202300379","volume":"62","author":"F Zeng","year":"2023","unstructured":"Zeng F et al (2023) Ferroptosis detection: from approaches to applications. Angew Chem Int Ed Engl 62(35):e202300379","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10961_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C et al (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21(1):47","journal-title":"Mol Cancer"},{"issue":"23","key":"10961_CR29","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","volume":"83","author":"W Zhang","year":"2023","unstructured":"Zhang W et al (2023) SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol Cell 83(23):4352\u20134369e8","journal-title":"Mol Cell"},{"issue":"1","key":"10961_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41419-025-07330-8","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z et al (2025) Inhibition of KLF5 promotes ferroptosis via the ZEB1\/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells. Cell Death Dis 16(1):28","journal-title":"Cell Death Dis"},{"key":"10961_CR31","doi-asserted-by":"publisher","first-page":"218243","DOI":"10.1016\/j.canlet.2026.218243","volume":"639","author":"Y Zhang","year":"2026","unstructured":"Zhang Y et al (2026) The Zeb1\/system X(c)(-) axis safeguards iron-loaded cancer-associated fibroblasts against ferroptosis and promotes immunosuppression in prostate cancer. Cancer Lett 639:218243","journal-title":"Cancer Lett"},{"key":"10961_CR32","doi-asserted-by":"crossref","unstructured":"Zhang S et al (2025) ZEB1 promotes chemoimmunotherapy resistance in pancreatic cancer models by downregulating chromatin acetylation of CXCL16. J Clin Invest 135(22)","DOI":"10.1172\/JCI195970"},{"issue":"4","key":"10961_CR33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41416-025-03072-8","volume":"133","author":"W Zhong","year":"2025","unstructured":"Zhong W et al (2025) TRIM26 deficiency potentially suppresses colorectal cancer liver metastasis through NF-kappaB-mediated M1-like tumor-associated macrophage polarization. Br J Cancer 133(4):435\u2013447","journal-title":"Br J Cancer"},{"issue":"1","key":"10961_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q et al (2024) Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther 9(1):55","journal-title":"Signal Transduct Target Ther"},{"key":"10961_CR35","doi-asserted-by":"publisher","first-page":"644901","DOI":"10.3389\/fcell.2021.644901","volume":"9","author":"Y Zhu","year":"2021","unstructured":"Zhu Y et al (2021) TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination. Front Cell Dev Biol 9:644901","journal-title":"Front Cell Dev Biol"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10961-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:19:26Z","timestamp":1792271966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10961-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10961"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10961-6","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest, financial or otherwise.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Lishui University (Ethics Approval Number: DWYX2026059).","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"287"}}